Hylomorph is a MedTech company that specializes in providing fibrotic encapsulation solutions in implantable medical devices.
Hylomorph has raised $5.1M in total funding. The most recent round was Series B. The last funding was announced in September 2023.
Hylomorph's investors include Verve Ventures, Zurcher Kantonal Bank, Venture Kick, Innosuisse, Eurostars.
Hylomorph is headquartered in Zurich, Switzerland.
Hylomorph is a MedTech company that specializes in providing fibrotic encapsulation solutions in implantable medical devices.
Hylomorph is at the Series B stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"Hylomorph — Funding & Investors." VCBacked, September 5, 2023, https://www.vcbacked.co/company/hylomorph. Accessed July 20, 2026.
VCBacked. (2023). Hylomorph — Funding & Investors. Retrieved July 20, 2026, from https://www.vcbacked.co/company/hylomorph
{{cite web |title=Hylomorph — Funding & Investors |url=https://www.vcbacked.co/company/hylomorph |website=VCBacked |access-date=July 20, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated